Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABBV

AbbVie (ABBV)

AbbVie Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ABBV
DateTimeSourceHeadlineSymbolCompany
02/06/20209:45AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
02/06/20206:00AMPR Newswire (Canada)SKYRIZI(MC), commercialisé par AbbVie, est désormais remboursé par les régimes publics d'assurance médicaments de l'Onta...NYSE:ABBVAbbVie Inc
02/06/20206:00AMPR Newswire (Canada)AbbVie's SKYRIZI™ Now Publicly Reimbursed in Ontario, Alberta, Saskatchewan and Quebec for the Treatment of Moderate to Sev...NYSE:ABBVAbbVie Inc
02/05/20201:37PMDow Jones NewsChina's Virus Outbreak Prompts Patients to Scramble for RemediesNYSE:ABBVAbbVie Inc
02/05/20209:27AMDow Jones NewsAbbVie's Rinvoq Meets Main Phase 3 Endpoints in Psoriatic ArthritisNYSE:ABBVAbbVie Inc
02/05/20208:45AMPR Newswire (US)RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic ArthritisNYSE:ABBVAbbVie Inc
02/04/20208:53AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
02/03/20209:55AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
01/31/202010:00AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
01/31/20208:05AMDow Jones NewsAbbVie: CHMP Recommends Approval of Shorter Maviret DurationNYSE:ABBVAbbVie Inc
01/31/20207:41AMDow Jones NewsAbbVie's Venclyxto Gets CHMP Positive OpinionNYSE:ABBVAbbVie Inc
01/31/20207:15AMPR Newswire (US)AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks i...NYSE:ABBVAbbVie Inc
01/31/20206:55AMPR Newswire (US)AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Chemotherapy-Free Combination Regimen for Patients with Previously...NYSE:ABBVAbbVie Inc
01/30/20209:29AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
01/29/20209:29AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
01/28/20209:43AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
01/28/20208:30AMGlobeNewswire Inc.Alector Announces Initiation of Phase 1b Study of AL003 in Alzheimer’s Disease PatientsNYSE:ABBVAbbVie Inc
01/27/20206:39PMDow Jones NewsU.S. Drugmakers Ship Therapies to China, Seeking to Treat CoronavirusNYSE:ABBVAbbVie Inc
01/27/20209:52AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
01/27/20208:17AMPR Newswire (US)AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan NotesNYSE:ABBVAbbVie Inc
01/27/20202:48AMDow Jones NewsAstraZeneca to Recover Global Rights to Brazikumab From AllerganNYSE:ABBVAbbVie Inc
01/27/20201:15AMPR Newswire (US)AbbVie and Allergan Announce Agreements to Divest Brazikumab and ZenpepNYSE:ABBVAbbVie Inc
01/24/20209:58AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
01/23/20209:52AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
01/20/20209:09AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
01/17/20209:41AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
01/16/20209:21AMDow Jones NewsForm 8.3 - [Allergan PLC]NYSE:ABBVAbbVie Inc
01/15/202010:05AMDow Jones NewsForm 8.3 - [Allergan plc]NYSE:ABBVAbbVie Inc
01/15/202010:01AMDow Jones NewsForm 8.3 - [Abbvie. Inc]NYSE:ABBVAbbVie Inc
01/14/202012:22PMDow Jones NewsAbbVie Shares Up; Skyrizi Met Endpoints in Phase 3 Plaque Psoriasis StudyNYSE:ABBVAbbVie Inc
 Showing the most relevant articles for your search:NYSE:ABBV

Your Recent History

Delayed Upgrade Clock